Current trends and perspectives on bioaccessibility and bioavailability of food bioactive peptides: in vitro and ex vivo studies

被引:7
|
作者
Alvarez-Olguin, Miguel A. [1 ]
Beltran-Barrientos, Lilia M. [1 ]
Hernandez-Mendoza, Adrian [1 ]
Gonzalez-Cordova, Aaron F. [1 ]
Vallejo-Cordoba, Belinda [1 ]
机构
[1] Ctr Invest Alimentac & Desarrollo, Coordinac Tecnol Alimentos Origen Anim, Hermosillo, Sonora, Mexico
关键词
simulated gastrointestinal digestion; bioaccessibility; bioactive peptides; bioactivity; SIMULATED GASTROINTESTINAL DIGESTION; ILE-PRO-PRO; ACE-INHIBITORY PEPTIDES; TRANSEPITHELIAL TRANSPORT; INTESTINAL-ABSORPTION; ANTIHYPERTENSIVE PEPTIDES; MILK; CACO-2; MODEL; IDENTIFICATION;
D O I
10.1002/jsfa.12077
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
The bioaccessibility and bioavailability of food-derived bioactive compounds are important issues when assessing their in vivo physiological health-promoting effects. Food components such as proteins and peptides are exposed to different proteases and peptidases during gastrointestinal digestion and absorption. Different in vitro approaches have therefore been developed to evaluate the bioaccessibility and stability of bioactive peptides. The static simulated gastrointestinal digestion model (SGD) was widely reported to assess the bioaccessibility of bioactive peptides. On the other hand, although the dynamic SGD model may better simulate human digestion, it has rarely been explored in bioaccessibility studies of food bioactive peptides due to its high cost and lack of standardization. For bioavailability studies, the Caco-2 cell monolayer model has been used extensively for the assessment of food bioactive peptides. In fact, very few reports using alternative methods for determining transepithelial transport of bioactive peptides have been employed. In this sense, ex vivo tissue-based models such as the Ussing chamber and the everted sac gut have been used. Current evidence supports the fact that using SGD with cell-based models for evaluating the bioaccessibility, absorption, and bioavailability of food-derived bioactive peptides, is the most commonly used approach. Nevertheless, SGD with ex vivo tissue-based models such as the everted sac, remains to be further explored because it seems to be the model that better mimics the physiological process - it is also fast and inexpensive, and several compounds may be tested simultaneously. In the present review, we discuss information available on the different in vitro approaches for the determination of bioaccessibility and bioavailability of food-derived bioactive peptides with special emphasis on ex vivo tissue-based models such as the everted sac and the Ussing chamber models. (c) 2022 Society of Chemical Industry.
引用
收藏
页码:6824 / 6834
页数:11
相关论文
共 50 条
  • [21] Current In Vitro Testing of Bioactive Peptides Is Not Valuable
    Foltz, Martin
    van der Pijl, Pieter C.
    Duchateau, Guus S. M. J. E.
    [J]. JOURNAL OF NUTRITION, 2010, 140 (01): : 117 - 118
  • [22] Delivery Systems to Enhance Bioaccessibility and Bioavailability of Bioactive Factors: Structure, Property, and Food Applications
    Zhang, Yaqiong
    Jia, Xin
    [J]. FOODS, 2023, 12 (16)
  • [23] Therapeutic Perspectives of Food Bioactive Peptides: A Mini Review
    Priya, Sulochana
    [J]. PROTEIN AND PEPTIDE LETTERS, 2019, 26 (09): : 664 - 675
  • [24] Oral Bioavailability Enhancement of Vancomycin Hydrochloride with Cationic Nanocarrier (Leciplex): Optimization, In Vitro, Ex Vivo, and In Vivo Studies
    Abdellatif, Menna M.
    Ahmed, Sara Mohamed
    El-Nabarawi, Mohamed A.
    Teaima, Mahmoud
    [J]. SCIENTIA PHARMACEUTICA, 2023, 91 (01)
  • [25] Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies
    Singh, Archu
    Neupane, Yub Raj
    Mangla, Bharti
    Kohli, Kanchan
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (10) : 3382 - 3395
  • [26] Peptides that anneal to natural collagen in vitro and ex vivo
    Chattopadhyay, Sayani
    Murphy, Christopher J.
    McAnulty, Jonathan F.
    Raines, Ronald T.
    [J]. ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (30) : 5892 - 5897
  • [27] Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations
    Uppoor, VRS
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 72 (1-3) : 127 - 132
  • [28] Perspectives, potentials and trends of ex vivo and in vivo optical molecular pathology
    Krafft, Christoph
    von Eggeling, Ferdinand
    Guntinas-Lichius, Orlando
    Hartmann, Arndt
    Waldner, Maximilian J.
    Neurath, Markus F.
    Popp, Juergen
    [J]. JOURNAL OF BIOPHOTONICS, 2018, 11 (01)
  • [29] Bioaccessibility and bioavailability of food-derived bioactive ingredients and their health-promoting effects: editorial
    Cai, Shengbao
    [J]. INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY, 2022, 57 (05): : 2569 - 2570
  • [30] In vitro assessment of the effect of microencapsulation techniques on the stability, bioaccessibility and bioavailability of mulberry leaf bioactive compounds
    Tchabo, William
    Kaptso, Giscard Kuate
    Ngea, Guillaume Legrand Ngolong
    Wang, Kenuo
    Bao, Guifeng
    Ma, Yongkun
    Wang, Xiangyang
    Mbofung, Carl Moses
    [J]. FOOD BIOSCIENCE, 2022, 47